Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to β-adrenergic stimulation in cirrhotic rats

Fundamental and Clinical Pharmacology

Volumn 20, Issue 5, 2006, Pages 461-471

  Ebrahimi, Farzad ^a   Tavakoli, Sina ^a   Hajrasouliha, Amir Reza ^a   Sadeghipour, Hamed ^a   Dehghani, Mehdi ^a   Ahmadi, Seyed Hossein ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

adrenergic receptor; Bile duct ligation; Cardiomyopathy; Cirrhosis; Endogenous opioid peptides; Nitric oxide

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; OPIATE PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BODY WEIGHT; CHRONOTROPISM; CONTROLLED STUDY; DOSE RESPONSE; HEART ATRIUM CONTRACTION; HEART WEIGHT; HEMODYNAMICS; INOTROPISM; MALE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BILE DUCTS; ENZYME INHIBITORS; GUANIDINES; HEART ATRIA; ISOPROTERENOL; LIGATION; LIVER CIRRHOSIS, BILIARY; MALE; MUSCLE CONTRACTION; NALTREXONE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OPIOID PEPTIDES; PAPILLARY MUSCLES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33748679793     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00431.x     Document Type: Article

References (55)

1. Vallance P., Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet (1991) 337 776-778.
2. Pozzi M., Carugo S., Boari G. et al. Functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (1997) 26 1131-1137.
3. Wong F., Liu P., Lilly L., Bomzon A., Blendis L. The role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin. Sci. (Lond.) (1999) 97 259-267.
4. Wong F., Girgrah N., Graba J., Allidina Y., Liu P., Blendis L. The cardiac response to exercise in cirrhosis. Gut (2001) 49 268-275.
5. Bernardi M., Rubboli A., Trevisani F. et al. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J. Hepatol. (1991) 12 207-216.
6. Grose R.D., Nolan J., Dillon J.F. et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J. Hepatol. (1995) 22 326-332.
7. Rayes N., Bechstein W.O., Keck H., Blumhardt G., Lohmann R., Neuhaus P. Cause of death after liver transplantation: an analysis of 41 cases in 382 patients. Zentralbl. Chir. (1995) 120 435-438.
8. Myers R.P., Lee S.S. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl. (2000) 6 S44-52.
9. Liu H., Ma Z., Lee S.S. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology (2000) 118 937-944.
10. Ma Z., Lee S.S., Meddings J.B. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signaling in rats with cirrhotic cardiomyopathy. J. Hepatol. (1997) 26 904-912.
11. Ma Z., Miyamoto A., Lee S.S. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology (1996) 110 1191-1198.
12. Ma Z., Zhang Y., Huet P.M., Lee S.S. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. J. Hepatol. (1999) 30 485-491.
13. Gaskari S.A., Liu H., Moezi L., Li Y., Baik S.K., Lee S.S. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br. J. Pharmacol. (2005) 146 315-323.
14. Bruix J., Bosch J., Kravetz D., Mastai R., Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology (1985) 88 430-435.
15. Millington W.R., Rosenthal D.W., Unal C.B., Nyquist-Battie C. Localization of pro-opiomelanocortin mRNA transcripts and peptides immunoreactivity in rat heart. Cardiovascular Res. (1999) 43 107-116.
16. Canossa M., Ventura C., Vaona I., Carboni L., Guarnieri C., Spampinato S. Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochim. Biophys. Acta (1993) 1172 247-250.
17. Sprighorn J.P., Claycomb W.C. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem. J. (1989) 258 73-77.
18. Springhorn J.P., Claycomb W.C. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am. J. Physiol. (1992) 263 H1560-H1566.
19. Xia Q., Sheng J.Z., Tai K.K., Wong T.M. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. J. Pharmacol. (1994) 268 930-934.
20. Mantelli L., Amerini S., Rubino A., Ledda F. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria. Eur. J. Pharmacol. (1990) 180 325-330.
21. Champion H.C., Kadowitz P.J. A-[Ala2] endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats. Am. J. Physiol. (1998) 74 H1690-H1697.
22. Gu H., Caugl J.F., Barron B.A., Caffrey J.L. Naloxone enhances cardiac contractile responses to epinephrine without altering epinephrine uptake from plasma. Circ. Shock (1990) 32 257-271.
23. Pepe S., Xiao R.P., Hohl C., Altschuld R., Lakatta E.G. 'Cross talk' between opioid peptide and adrenoceptor signaling in isolated rat heart. Circulation (1997) 95 2122-2129.
24. Xiao R.P., Pepe S., Spurgeon H.A., Capogrossi M.C., Lakatta E.G. Opioid peptide receptor stimulation reserves beta-adrenergic effects in rat heart cells. Am. J. Physiol. (1997) 272 H797-H805.
25. Yu X.C., Li H.Y., Wang H.X., Wong T.M. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes - cross talk between κ-opioid and β-adrenergic receptors. J. Mol. Cell Cardiol. (1998) 30 405-413.
26. Wong T.M., Shan J. Modulation of sympathetic actions on the heart by opioid receptor stimulation. J. Biomed. Sci. (2001) 8 299-306.
27. Yu X.C., Wang H-X., Pei J-M., Wong T.M. Antiarrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J. Mol. Cell Cardiol. (1999) 31 1809-1819.
28. Yu X.C., Wang H.X., Zhang W.M., Wong T.M. Cross-talk between cardiac κ-opioid and β-adrenergic receptors in developing hypertensive rats. J. Mol. Cell Cardiol. (1999) 31 597-605.
29. Shan J., Yu X.C., Fung M.L., Wong T.M. Attenuated "cross talk" between kappa-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats. Pflugers Arch. (2002) 444 126-132.
30. Hajrasouliha A.R., Tavakoli S., Jabehdar-Maralani P. et al. Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides. J. Hepatol. (2005) 43 491-498.
31. Borhani A.A., Houshmand G., Samini M. et al. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids. Eur. J. Pharmacol. (2005) 514 183-189.
32. Ebrahimi F., Tavakoli S., Hajrasouliha A.R. et al. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats. Eur. J. Pharmacol. (2005) 523 93-100.
33. Gaskari S.A., Mani A.R., Ejtemaei-Mehr S. et al. Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fundam. Clin. Pharmacol. (2002) 16 273-279.
34. Namiranian K., Samini M., Ejtemaei Mehr S. et al. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems. Eur. J. Pharmacol. (2001) 423 185-193.
35. Thornton J.R., Losowsky M.S. Plasma leucine enkephalin is increased in liver disease. Gut (1989) 30 1392-1395.
36. Thornton J.R., Dean H.G., Losowsky M.S. Do increased catecholamines and plasma methionine enkephalin in cirrhosis promote bleeding oesophageal varices? Q. J. Med. (1988) 68 541-551.
37. Sieber C.C., Lopez-Talavera J.C., Groszmann R.J. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology (1993) 104 1750-1754.
38. Mathie R.T., Ralevic V., Moore K.P., Burnstock G. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide? Hepatology (1996) 23 130-136.
39. Schmandra T.C., Folz I.C., Kimpel M., Fleming I., Holzer K., Hanisch E.W. Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro. Eur. J. Gastroenterol. Hepatol. (2001) 13 957-962.
40. Nunes H., Lebrec D., Mazmanian M. et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am. J. Respir. Crit. Care Med. (2001) 164 879-885.
41. Wei C.L., Hon W.M., Lee K.H., Khoo H.E. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Liver Int. (2005) 25 647-656.
42. Hajrasouliha A.R., Tavakoli S., Jabehdar-Maralani P. et al. Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids. Eur. J. Pharmacol. (2004) 499 307-313.
43. Mani A.R., Nahavandi A., Moosavi M., Safarinejad R., Dehpour A.R. Dual nitric oxide mechanisms of cholestasis-induced bradycardia in the rat. Clin. Exp. Pharmacol. Physiol. (2002) 29 905-908.
44. Song D., Sharkey K.A., Breitman D.R., Zhang Y., Lee S.S. Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats. Am. J. Physiol. Gastrointest. Liver Physiol. (2001) 280 G420-G430.
45. Nahavandi A., Dehpour A.R., Mani A.R., Homayounfar H., Abdoli A., Abdolhoseini M.R. The role of nitric oxide in bradycardia of rats with obstructive cholestasis. Eur. J. Pharmacol. (2001) 411 135-141.
46. Lee S.S. Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy? Hepatology (2003) 38, 1089-1091.
47. Ruiz-del-Arbol L., Urman J., Fernandez J. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology (2003) 38 1210-1218.
48. Thornton J.R., Dean H., Losowsky M.S. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut (1988) 29, 1167-1172.
49. Lee S.S., Hadengue A., Moreau R., Girod C., Jiron M.I., Lebrec D. Naloxone does not alter hemodynamics in cirrhosis. Studies in humans and rats. J. Hepatol. (1987) 5 149-153.
50. Joubert P. Cholic acid and the heart: in vitro studies of the effect on heart rate and myocardial contractility in the rat. Clin. Exp. Pharmacol. Physiol. (1978) 5 9-16.
51. Tripathi O., Ray M., Bajpai V.K. et al. Effects of sodium deoxycholate on the mechanical and electrical activities and ultrastructure of guinea pig atria. Biomed. Biochim. Acta (1988) 47 901-914.
52. Kinugasa T., Uchida K., Kadowaki M., Takase H., Nomura Y., Saito Y. Effect of bile duct ligation on bile acid metabolism in rats. J. Lipid Res. (1981) 22 201-207.
53. Gumpricht E., Dahl R., Yerushalmi B., Devereaux M. W., Sokol R.J. Nitric oxide ameliorates hydrophobic bile acid-induced apoptosis in isolated rat hepatocytes by non-mitochondrial pathways. J. Biol. Chem. (2002) 277 25823-25830.
54. van den Brink O.W., Delbridge L.M., Rosenfeldt F.L. et al. Endogenous cardiac opioids: Enkephalins in adaptation and protection of the heart. Heart Lung Circ. (2003) 12 178-187.
55. Drexler H., Kastner S., Strobel A., Studer R., Brodde O.E., Hasenfuss G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J. Am. Coll. Cardiol. (1998) 32 955-963.